glp-1 pet scan imaging news Nareg Varjabedian: Emerging Clinical Insight - Agonists May Interfere with FDG PET-CT Brown Adipose Tissue Mimicking Head

I had tried diet pills in the past, but nothing really worked long term. However, within a month of starting Semaglutide, John noticed a significant reduction in his appetite

These ingredient-level findings do not mean NuraPatch replicates the effects seen in these studies, particularly since most research involves oral supplementation rather than transdermal patches

Demand for GLP-1 drugs, originally developed to treat Type 2 diabetes, has surged across the U.S., driven by their effectiveness at helping patients lose significant amounts of weight

Early research suggests these medications may ease depressive symptoms by dampening inflammation and influencing brain signaling, though clinical data remain limited

As we move toward a new era of oral therapeutics, how might this shift our long-term treatment algorithms and conversations with patients about managing obesity as the chronic disease it is?